Skip to content
Home/Companies/Biotech/JeNaCell
JE

JeNaCell

Biotech·Germany·Exited 2021·Held 6yr

JeNaCell is a biotech company, headquartered in Germany.

Entry
2015
Hold
6yr
Exit
2021
Est. EV
–

Who owns JeNaCell?

JeNaCell was owned by bm-t Beteiligungsmanagement Thueringen through Thueringer WachstumsBeteiligungsFonds (WBF) (2015 vintage) from 2015 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

bm-t Beteiligungsmanagement Thueringen
Investor
bm-t Beteiligungsmanagement Thueringen
Thueringer WachstumsBeteiligungsFonds (WBF) · 2015 · Growth

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Thueringer WachstumsBeteiligungsFonds (WBF)

Other portfolio companies in the same fund.

evan GmbH
Exited 2021
SoftwareGermany· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings